Published in Blood Weekly, November 13th, 1995
New virucidal procedures are required for HAV and parvovirus, non-enveloped viruses that are resistant to current inactivation methods. This inability, along with sporadic reports of the possible transmission of such viruses by blood derivatives, has prompted the search for new virucidal procedures, indicated Dr. Bernard Horowitz, Vice President and Chief Scientific Officer, Melville Biologics, Inc., New York, New York.
Both HAV and parvovirus have single stranded genomes, and are expected to be...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.